Cegedim SA
13.50
19-February-25 11:14:30
15 minutes delayed
Stocks
+0.20
+1.50%
Today's range
13.33 - 13.50
ISIN
FR0000053506
Source
Cboe
-
Cegedim off to a dynamic start in 2023
27 Apr 2023 11:50:00 By Nasdaq GlobeNewswire
-
Cegedim: Release of its 2022 Universal Registration Document
13 Apr 2023 12:00:00 By Nasdaq GlobeNewswire
-
Cegedim: Full year 2022 results
23 Mar 2023 12:45:00 By Nasdaq GlobeNewswire
-
Cegedim: revenue growth continued in 2022
26 Jan 2023 11:45:00 By Nasdaq GlobeNewswire
-
Cegedim: Half-year liquidity contract statement
04 Jan 2023 12:00:00 By Nasdaq GlobeNewswire
-
Cegedim: Growth continued in the third quarter of 2022
27 Oct 2022 11:45:00 By Nasdaq GlobeNewswire
-
Cegedim acquires French medical data expert Clinityx, strengthening its position in Real-World-Data
20 Oct 2022 11:45:00 By Nasdaq GlobeNewswire
-
Cegedim: Release of 2022 Half-Year Financial Report
20 Sep 2022 11:50:00 By Nasdaq GlobeNewswire
-
20 Sep 2022 11:45:00 By Nasdaq GlobeNewswire
-
Cegedim : Growth picked up speed in Q2 2022
28 Jul 2022 11:45:00 By Nasdaq GlobeNewswire
-
Cegedim: Half-year liquidity contract statement
25 Jul 2022 11:45:00 By Nasdaq GlobeNewswire
-
Cegedim: 2022 off to a promising start
28 Apr 2022 11:50:00 By Nasdaq GlobeNewswire
-
Cegedim: Release of its 2021 Universal Registration Document
04 Apr 2022 11:45:00 By Nasdaq GlobeNewswire
-
Cegedim full-year 2021 results: highly resilient business model
24 Mar 2022 12:45:00 By Nasdaq GlobeNewswire
-
01 Mar 2022 12:30:00 By Nasdaq GlobeNewswire
-
Cegedim: Steady revenue growth in 2021
27 Jan 2022 11:45:00 By Nasdaq GlobeNewswire
-
Cegedim: Half-year liquidity contract statement
13 Jan 2022 11:45:00 By Nasdaq GlobeNewswire
-
Cegedim: Robust growth continued in 3Q 2021
28 Oct 2021 11:45:00 By Nasdaq GlobeNewswire
-
14 Oct 2021 02:30:00 By Nasdaq GlobeNewswire
-
Cegedim: Release of its 2021 Half-Year Financial Report
27 Sep 2021 12:30:00 By Nasdaq GlobeNewswire